Parkside Financial Bank & Trust’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $395 | Sell |
400
-275
| -41% | -$272 | ﹤0.01% | 2622 |
|
2025
Q1 | $972 | Buy |
675
+275
| +69% | +$396 | ﹤0.01% | 2115 |
|
2024
Q4 | $880 | Hold |
400
| – | – | ﹤0.01% | 1763 |
|
2024
Q3 | $656 | Hold |
400
| – | – | ﹤0.01% | 1781 |
|
2024
Q2 | $880 | Hold |
400
| – | – | ﹤0.01% | 1676 |
|
2024
Q1 | $1.07K | Hold |
400
| – | – | ﹤0.01% | 1601 |
|
2023
Q4 | $1.2K | Hold |
400
| – | – | ﹤0.01% | 1580 |
|
2023
Q3 | $392 | Hold |
400
| – | – | ﹤0.01% | 1943 |
|
2023
Q2 | $560 | Sell |
400
-300
| -43% | -$420 | ﹤0.01% | 1885 |
|
2023
Q1 | $1.11K | Buy |
700
+300
| +75% | +$477 | ﹤0.01% | 1829 |
|
2022
Q4 | $2.49K | Hold |
400
| – | – | ﹤0.01% | 1605 |
|
2022
Q3 | $3K | Hold |
400
| – | – | ﹤0.01% | 1395 |
|
2022
Q2 | $3K | Hold |
400
| – | – | ﹤0.01% | 1425 |
|
2022
Q1 | $2K | Hold |
400
| – | – | ﹤0.01% | 1590 |
|
2021
Q4 | $2K | Hold |
400
| – | – | ﹤0.01% | 1599 |
|
2021
Q3 | $5K | Hold |
400
| – | – | ﹤0.01% | 1228 |
|
2021
Q2 | $8K | Hold |
400
| – | – | ﹤0.01% | 1037 |
|
2021
Q1 | $11K | Hold |
400
| – | – | ﹤0.01% | 900 |
|
2020
Q4 | $10K | Hold |
400
| – | – | ﹤0.01% | 873 |
|
2020
Q3 | $15K | Hold |
400
| – | – | 0.01% | 728 |
|
2020
Q2 | $21K | Hold |
400
| – | – | 0.01% | 625 |
|
2020
Q1 | $13K | Sell |
400
-100
| -20% | -$3.25K | ﹤0.01% | 661 |
|
2019
Q4 | $30K | Hold |
500
| – | – | 0.01% | 548 |
|
2019
Q3 | $18K | Hold |
500
| – | – | 0.01% | 648 |
|
2019
Q2 | $23K | Hold |
500
| – | – | 0.01% | 598 |
|
2019
Q1 | $20K | Hold |
500
| – | – | 0.01% | 600 |
|
2018
Q4 | $23K | Hold |
500
| – | – | 0.01% | 529 |
|
2018
Q3 | $22K | Hold |
500
| – | – | 0.01% | 583 |
|
2018
Q2 | $20K | Hold |
500
| – | – | 0.01% | 590 |
|
2018
Q1 | $36K | Sell |
500
-400
| -44% | -$28.8K | 0.01% | 414 |
|
2017
Q4 | $59K | Hold |
900
| – | – | 0.02% | 321 |
|
2017
Q3 | $45K | Hold |
900
| – | – | 0.02% | 364 |
|
2017
Q2 | $42K | Buy |
+900
| New | +$42K | 0.02% | 369 |
|